Integration of Specialized Palliative Care with Oncological Treatment in Patients with Advanced Pancreatic Cancer.
Anders BojessonEva BrunJakob EberhardMikael SegerlantzPublished in: Journal of pancreatic cancer (2022)
Enrollment in SPC for longer than 30 days may lower the risk of receiving futile palliative chemotherapy at the end of life, compared with patients enrolled in SPC for 30 days or less before death. Enrollment in SPC lowers the risk of dying in a hospital.
Keyphrases
- palliative care
- advanced cancer
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- health insurance
- healthcare
- prognostic factors
- prostate cancer
- peritoneal dialysis
- rectal cancer
- radical prostatectomy
- emergency department
- squamous cell carcinoma
- combination therapy
- affordable care act
- patient reported
- acute care
- replacement therapy
- drug induced